Filip Forsberg, Giannis Antetokounmpo Join Nashville Soccer Club Ownership Group
2.3.2023 17:00:00 EET | Business Wire | Press release
As Nashville Soccer Club enters its fourth season in Major League Soccer, and second at GEODIS Park, principal owner John Ingram announced today that leading scorer in Nashville Predator history Filip Forsberg and two-time MVP and NBA Champion Giannis Antetokounmpo have joined the team’s ownership group.
Antetokounmpo is joined in ownership by his brothers Thanasis, Kostas and Alex as well – all of whom play professional basketball worldwide. Thanasis joined Giannis in winning the NBA Championship with the Milwaukee Bucks in 2021, and Kostas won one with the Los Angeles Lakers in 2020.
The announcement of the new owners continues the strong momentum built by Nashville SC in the lead-up to the 2023 season, highlighted by its 'Man in Black’ jersey collaboration with the Estate of Johnny Cash. That momentum continued with a 2-0 victory over New York City FC in front of 28,051 fans at GEODIS Park this past Saturday.
Forsberg and Antetokounmpo join a robust and diverse ownership group whose most recent additions include Reese Witherspoon, her husband Jim Toth and Derrick Henry.
“Nashville is the best sports city in the country, and I am extremely blessed to now be involved with two of our pro teams,” said Forsberg. “Our city is one big family and fanbase, and we support each other on and off the field. Nashville SC has been such a great addition to our sports culture, and joining the ownership group was an opportunity I wasn’t going to pass up. I grew up a Liverpool FC fan in Sweden, and after today I am happy to add a second set of colors to cheer for!”
“My father was a professional soccer player, and it was the first sport I fell in love with in Greece,” said Antetokounmpo. “I’ve always had the dream of owning a soccer team. When my brothers and I explored Nashville SC, we knew it was a team and a city that we wanted to get involved with. I couldn’t be more excited to join the Boys in Gold, and can’t wait to come to a match at GEODIS Park soon!”
“Soccer is a global sport, and our newest owners once again reinforce our club’s commitment to being a global team,” said Ingram. “Filip and Giannis are not just amazing athletes – they are ambassadors for their respective sports, role models for millions and advocates in their hometowns and worldwide. We share a common belief that our teams not only play to the highest standards, but also lift up their communities and help those who need it most.”
Nashville SC takes on the road to face the New York Red Bulls at 6:30 p.m. CT on Saturday, March 4. Fans ns can follow the action on the MLS Season Pass on the Apple TV app and the club on its digital and social channels on Instagram, Facebook, TikTok, Twitter and Spotify.
MEDIA RESOURCES:
- Nashville SC Media Center with news, b-roll from training, match notes, other video and photo resources
- Media looking to follow NSC on social media can find the club on TikTok, Twitter and Instagram with the handle @NashvilleSC. For Facebook and YouTube please use “Nashville Soccer Club”
- The official club hashtag when referring to Nashville SC on social media is #EveryoneN
FOR MORE INFORMATION, CONTACT: Zach Hunt, zach@tsgnashville.com, 615.321.3110.
About Nashville SC
Nashville SC joined Major League Soccer on Feb. 29, 2020 in front of the largest attendance ever recorded for a soccer match in the State of Tennessee. In its inaugural MLS season, Nashville SC defeated expectations by becoming the second MLS expansion side to win and advance to the Conference Semifinals in the 2020 Audi MLS Cup Playoffs. Nashville SC returned to the 2021 Audi MLS Cup Playoffs in its sophomore season after becoming just the seventh team in MLS history to go unbeaten at home in a season. Nashville SC inaugurated GEODIS Park, the largest soccer-specific stadium in the United States and Canada, in front of a 30,109-sellout crowd on May 1, 2022. For more information, visit NashvilleSC.com and follow the club at @NashvilleSC on Instagram , Facebook , Twitter and Spotify .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005537/en/
Contact information
Zach Hunt, zach@tsgnashville.com, 615.321.3110
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 09:00:00 EET | Press release
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, the largest radiology practice in the U.S, with more than 4,000 radiologists in its network. Cognita CXR1 applies a proprietary
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 09:00:00 EET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 09:00:00 EET | Press release
For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network operators over the air in just a few seconds, without sending a technician and with minimal disruption to merchants’ activity. For merchants, the experience is seamless: if a network becomes unstable, the payment terminal can automatically reconnect to another available network, often without the merchant even noticing. This deployment represents one of the first large-scale implementations of the SGP.32 eSIM specifi
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 09:00:00 EET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency 1 , and Core EBITDA 2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 08:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new product launches across Galderma’s full portfoli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom